NTRK1 and neurodegenerative disease: Alterations of BDNF/TrkB signaling in the cortical and hippocampal area, in fact, were indicated as a hallmark of numerous neurodegenerative diseases, and a Trk agonist-mediated restoration holds the promise of a disease-modifying treatment (reviewed by Longo and Massa, 2013).